CD44 and ovarian cancer: Importantly, in mice transplanted with chemoresistant CD44+ ovarian cancer stem cell xenografts, multiple intraperitoneal treatments with sublethal doses of CPE significantly inhibited ovarian cancer progression (Casagrande et al., 2011).